Jump to content

Talipexole

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rich Farmbrough (talk | contribs) at 00:50, 15 May 2009 (clean up- spelling of "et al." using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Talipexole
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 6-allyl-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[4,5-d]azepin-2-amine
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H15N3S
Molar mass209.31 g/mol g·mol−1
3D model (JSmol)
  • C=CCN1CCC2=C(CC1)SC(=N2)N

Talipexole is a dopamine agonist that has been proposed as an antiparkinsonian agent.[1] It also has alpha-adrenergic agonist activity.

References

  1. ^ Kitamura Y, Kosaka T, Kakimura JI; et al. (1998). "Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells". Mol. Pharmacol. 54 (6): 1046–54. PMID 9855633. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)